Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1555-1562
Published online before print March 10, 2008, doi: 10.1161/CIRCULATIONAHA.107.732073
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/12/1555    most recent
CIRCULATIONAHA.107.732073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terrovitis, J.
Right arrow Articles by Abraham, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terrovitis, J.
Right arrow Articles by Abraham, M. R.
Related Collections
Right arrow Imaging
Right arrow CT and MRI
Right arrowRelated Article

(Circulation. 2008;117:1555-1562.)
© 2008 American Heart Association, Inc.


Imaging

Magnetic Resonance Imaging Overestimates Ferumoxide-Labeled Stem Cell Survival After Transplantation in the Heart

John Terrovitis, MD; Matthias Stuber, PhD; Amr Youssef, MD; Steve Preece, BS; Michelle Leppo, BS; Eddy Kizana, MD, PhD; Michael Schär, PhD; Gary Gerstenblith, MD; Robert G. Weiss, MD; Eduardo Marbán, MD, PhD; M. Roselle Abraham, MD

From Johns Hopkins University, Division of Cardiology, Department of Medicine (J.T., A.Y., S.P., M.L., E.K., G.G., R.G.W., E.M., M.R.A.), and Division of MR Research, Department of Radiology (M. Stuber, M. Schär), Baltimore, Md, and Philips Healthcare (M. Schär), Cleveland, Ohio. Dr Marbán is currently at The Heart Institute, Cedars Sinai Medical Center, Los Angeles, Calif. Dr Youssef is currently at the Ain Shams University, Cairo, Egypt.

Correspondence to M. Roselle Abraham, MD, Johns Hopkins University, Division of Cardiology, Department of Medicine, Rutland Ave, Ross 871, Baltimore, MD 21205. E-mail mabraha3{at}jhmi.edu

Received December 14, 2006; accepted January 23, 2008.

Background— Stem cell labeling with iron oxide (ferumoxide) particles allows labeled cells to be detected by magnetic resonance imaging (MRI) and is commonly used to track stem cell engraftment. However, the validity of MRI for distinguishing surviving ferumoxide-labeled cells from other sources of MRI signal, for example, macrophages containing ferumoxides released from nonsurviving cells, has not been thoroughly investigated. We sought to determine the relationship between the persistence of iron-dependent MRI signals and cell survival 3 weeks after injection of syngeneic or xenogeneic ferumoxides-labeled stem cells (cardiac-derived stem cells) in rats.

Methods and Results— We studied nonimmunoprivileged human and rat cardiac-derived stem cells and human mesenchymal stem cells doubly labeled with ferumoxides and β-galactosidase and injected intramyocardially into immunocompetent Wistar-Kyoto rats. Animals were imaged at 2 days and 3 weeks after stem cell injection in a clinical 3-T MRI scanner. At 2 days, injection sites of xenogeneic and syngeneic cells (cardiac-derived stem cells and mesenchymal stem cells) were identified by MRI as large intramyocardial signal voids that persisted at 3 weeks (50% to 90% of initial signal). Histology (at 3 weeks) revealed the presence of iron-containing macrophages at the injection site, identified by CD68 staining, but very few or no β-galactosidase–positive stem cells in the animals transplanted with syngeneic or xenogeneic cells, respectively.

Conclusions— The persistence of significant iron-dependent MRI signal derived from ferumoxide-containing macrophages despite few or no viable stem cells 3 weeks after transplantation indicates that MRI of ferumoxide-labeled cells does not reliably report long-term stem cell engraftment in the heart.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1499. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cancer Res.Home page
M. R. Loebinger, P. G. Kyrtatos, M. Turmaine, A. N. Price, Q. Pankhurst, M. F. Lythgoe, and S. M. Janes
Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles
Cancer Res., December 1, 2009; 69(23): 8862 - 8867.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Higuchi, M. Anton, A. Saraste, K. Dumler, J. Pelisek, S. G. Nekolla, F. M. Bengel, and M. Schwaiger
Reporter Gene PET for Monitoring Survival of Transplanted Endothelial Progenitor Cells in the Rat Heart After Pretreatment with VEGF and Atorvastatin
J. Nucl. Med., November 1, 2009; 50(11): 1881 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Gianella, U. Guerrini, M. Tilenni, L. Sironi, G. Milano, E. Nobili, S. Vaga, M. C. Capogrossi, E. Tremoli, and M. Pesce
Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues
Cardiovasc Res, October 31, 2009; (2009) cvp325v2.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F.-L. Xiang, X. Lu, L. Hammoud, P. Zhu, P. Chidiac, J. Robbins, and Q. Feng
Cardiomyocyte-Specific Overexpression of Human Stem Cell Factor Improves Cardiac Function and Survival After Myocardial Infarction in Mice
Circulation, September 22, 2009; 120(12): 1065 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Kraitchman and J. W.M. Bulte
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1025 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The year in cardiac imaging.
J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Terrovitis, K. F. Kwok, R. Lautamaki, J. M. Engles, A. S. Barth, E. Kizana, J. Miake, M. K. Leppo, J. Fox, J. Seidel, et al.
Ectopic Expression of the Sodium-Iodide Symporter Enables Imaging of Transplanted Cardiac Stem Cells In Vivo by Single-Photon Emission Computed Tomography or Positron Emission Tomography
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1652 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Wu
Molecular Imaging: Antidote to Cardiac Stem Cell Controversy
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1661 - 1664.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme
Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells
Circ. Res., November 7, 2008; 103(10): 1058 - 1071.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. E.A. van der Bogt, A. Y. Sheikh, S. Schrepfer, G. Hoyt, F. Cao, K. J. Ransohoff, R.-J. Swijnenburg, J. Pearl, A. Lee, M. Fischbein, et al.
Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia
Circulation, September 30, 2008; 118(14_suppl_1): S121 - S129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Togel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F315 - F321.
[Abstract] [Full Text] [PDF]